The safety of therapeutic monoclonal antibodies: implications for cardiovascular disease and targeting the PCSK9 pathway.
Atherosclerosis. 2013 May;228(1):18-28. doi: 10.1016/j.atherosclerosis.2013.01.044. Epub 2013 Feb 8.
Atherosclerosis. 2013.
PMID: 23466067
Review.